MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia
出版年份 2014 全文链接
标题
MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia
作者
关键词
-
出版物
BLOOD
Volume 124, Issue 2, Pages 263-272
出版商
American Society of Hematology
发表日期
2014-04-03
DOI
10.1182/blood-2013-09-525741
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia
- (2013) A. Pession et al. BLOOD
- Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
- (2013) A. J. Deshpande et al. BLOOD
- Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells
- (2013) H. Ding et al. HAEMATOLOGICA
- Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants
- (2013) E. M. C. Driessen et al. HAEMATOLOGICA
- Sox4 cooperates with CREB in myeloid transformation
- (2012) S. Sandoval et al. BLOOD
- The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
- (2012) William J. Harris et al. CANCER CELL
- Model for MLL translocations in therapy-related leukemia involving topoisomerase II -mediated DNA strand breaks and gene proximity
- (2012) I. G. Cowell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytotoxicity of farnesyltransferase inhibitors in lymphoid cells mediated by MAPK pathway inhibition and Bim up-regulation
- (2011) H. Ding et al. BLOOD
- Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
- (2011) T. E. Witzig et al. BLOOD
- A Phase I Clinical-Pharmacodynamic Study of the Farnesyltransferase Inhibitor Tipifarnib in Combination with the Proteasome Inhibitor Bortezomib in Advanced Acute Leukemias
- (2011) J. E. Lancet et al. CLINICAL CANCER RESEARCH
- Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis
- (2011) J. Y. Guo et al. GENES & DEVELOPMENT
- Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group
- (2011) J N Berman et al. LEUKEMIA
- MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study
- (2011) M Pigazzi et al. LEUKEMIA
- The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia
- (2011) B V Balgobind et al. LEUKEMIA
- Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth
- (2011) G Fournier et al. ONCOGENE
- BAG1: The Guardian of Anti-Apoptotic Proteins in Acute Myeloid Leukemia
- (2011) Sanja Aveic et al. PLoS One
- Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6
- (2010) M. Liedtke et al. BLOOD
- A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome
- (2010) Elias Jabbour et al. CANCER
- Novel Therapies for Myelodysplastic Syndromes
- (2010) David P. Steensma HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Gene Expression–Based Classification As an Independent Predictor of Clinical Outcome in Juvenile Myelomonocytic Leukemia
- (2010) Silvia Bresolin et al. JOURNAL OF CLINICAL ONCOLOGY
- Pediatric early T-cell precursor leukemia with NF1 deletion and high-sensitivity in vitro to tipifarnib
- (2010) C Biagi et al. LEUKEMIA
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
- (2009) B. V. Balgobind et al. BLOOD
- Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation
- (2009) R Ono et al. LEUKEMIA
- RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia
- (2008) W.-I. Kim et al. BLOOD
- The Signaling Adaptor p62 Is an Important NF-κB Mediator in Tumorigenesis
- (2008) Angeles Duran et al. CANCER CELL
- Targeting Ras in Myeloid Leukemias
- (2008) B. S. Braun et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started